Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ranitidine.

W B Strum

    JAMA
    |October 14, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Ranitidine, an H2-receptor antagonist, effectively treats duodenal ulcers and related conditions. It offers similar therapeutic effects to cimetidine but with notable clinical advantages.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Long-term use of mesalamine (Rowasa) suppositories in remission maintenance of ulcerative proctitis.

    The American journal of gastroenterology·2000
    Same author

    Effect of combined anticoagulation and low-dose aspirin treatment on upper gastrointestinal bleeding.

    Digestive diseases and sciences·1997
    Same author

    Abstinence in alcoholic chronic pancreatitis. Effect on pain and outcome.

    Journal of clinical gastroenterology·1995
    Same author

    Pleomorphic pancreatic sarcoma mimicking pancreatic pseudocyst: CT appearance.

    AJR. American journal of roentgenology·1992
    Same author

    Upper gastrointestinal bleeding from a duodenal duplication: an unusual complication of a rare disease.

    Gastrointestinal endoscopy·1989
    Same author

    Update on traveler's diarrhea.

    Postgraduate medicine·1988
    Same journal

    Deescalation, Discontinuation, and Deimplementation Trials: Evaluating Whether and How to Do Less.

    JAMA·2026
    Same journal

    Surgical and Endoscopic Therapies for GERD.

    JAMA·2026
    Same journal

    The Psychedelic Therapies Executive Order: On Approval and Clinical Readiness.

    JAMA·2026
    Same journal

    "Suturing": Love, Death, and Perfection's Limits.

    JAMA·2026
    Same journal

    What Is Low Back Pain?

    JAMA·2026
    Same journal

    From Silicon Valley to the Vatican-The Expanding Debate on AI Ethics.

    JAMA·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Gastroenterology

    Background:

    • Ranitidine is a recently introduced H2-receptor antagonist.
    • It is indicated for treating acute duodenal ulcer disease, Zollinger-Ellison syndrome, and systemic mastocytosis with gastric hypersecretion.

    Purpose of the Study:

    • To present the pharmacokinetics, efficacy, adverse effects, and clinical utility of ranitidine.
    • To compare ranitidine with its predecessor, cimetidine.

    Main Methods:

    • Review of pharmacokinetic data.
    • Analysis of clinical efficacy studies.
    • Evaluation of adverse effect profiles.
    • Assessment of clinical utility in comparison to cimetidine.

    Main Results:

    • Ranitidine demonstrates favorable pharmacokinetic properties.

    Related Experiment Videos

  • The drug exhibits significant efficacy in treating specified gastrointestinal conditions.
  • Adverse effects are generally mild and comparable to cimetidine.
  • Ranitidine presents distinct advantages over cimetidine in clinical applications.

    • Conclusions:

    • Ranitidine is a valuable therapeutic option for conditions involving gastric acid hypersecretion.
    • Its comparable efficacy and improved clinical utility make it a significant advancement over cimetidine.